Vial is the CRO built for biotech. Engineered to deliver faster and more efficient trials. CRO led by Clinical Operations experts.
Location: United States, California, San Francisco
Employees: 51-200
Total raised: $77M
Founded date: 2020
Funding Rounds 2
| Date | Series | Amount | Investors |
| 18.06.2025 | - | $10M | ATEL Capit... |
| 30.11.2022 | Series B | $67M | - |
Mentions in press and media 9
| Date | Title | Description |
| 18.06.2025 | ATEL Ventures, Inc. Provides $10M Venture Debt to Emerging Biotech Company, Vial | ATEL Ventures logo We are reimagining drug development. The financing from ATEL complements our historical equity funding and supports our ability to accelerate the number of clinical stage assets in our pipeline.” — Simon Burns, CEO, VialS... |
| 09.04.2024 | Хотите похудеть – НЕ спрашивайте меня как. Часть 2: Оземпик — опыты на себе | Кратко для лиги лени: Оземпик как средство для похудения работает, но ограниченно годится для ИТ, и дает осечки примерно 50 на 50 побочки. В первой части я попробовал рассмотреть хоть как-то эффективные методы, кроме «надо меньше есть». Это... |
| 19.02.2024 | Хотите похудеть – НЕ спрашивайте меня как — 2: Оземпик | В первой части я попробовал рассмотреть хоть как-то эффективные методы, кроме «надо меньше есть». Дальше будет про оземпик. Предисловие. Рассуждать про диеты очень легко, хоть в стиле «мне помогло», хоть в стиле «я читал что помогает». Поче... |
| 13.02.2023 | Vial Partners With Egnyte to Integrate Life Sciences eTMF Solution into Clinical Trial Platform | Vial, a technology-first CRO, has announced a partnership with Egnyte, a leader in cloud content security and governance, to integrate its Life Sciences eTMF (electronic trial master file) solution into Vial’s platform. Egnyte eTMF is a 21 ... |
| 10.02.2023 | Vial Partners with Egnyte to Integrate Life Sciences’ eTMF Solution into Their Clinical Trial Platform | Vial, a technology-first CRO, has announced a partnership with Egnyte, a leader in cloud content security and governance, to integrate its Life Sciences eTMF (electronic trial master file) solution into Vial’s platform. Egnyte eTMF is a 21 ... |
| 13.01.2023 | Buzzy healthtech startup Vial slashed an entire division weeks before a $67 million raise from General Catalyst. Insiders say they had no idea the layoffs were coming. | Vial CRO and co-founder Andrew Brackin started the company in 2020 after stints at startup Growth and insurance brokerage Newfront. He was also a fellow at the Thiel Foundation in 2013. The Thiel Foundation This story is available exclusive... |
| 30.11.2022 | Vial Raises $67M in Series B Funding | Vial, a San Francisco, CA-based Contract Research Organization (CRO), raised $67M in Series B funding. The round was led by General Catalyst with participation from Byers Capital, and BoxGroup. The company intends to use the funds to accele... |
| - | Vial | “Vial is a hyper scalable biotech - advancing programs into the clinic powered by dramatically cheaper trials and computationally designed therapeutics.” |
| - | Vial | “Vial is the CRO built for biotech. Engineered to deliver faster and more efficient trials. CRO led by Clinical Operations experts.” |